Fat-Soluble Vitamins: A, D, E, K — MCQs
Which of the following is NOT a manifestation of vitamin E deficiency?
Warfarin's mechanism of action is
Vitamin A intoxication causes injury to
All of the following statements are true except:
Which of the following clotting factors in a patient on Warfarin therapy would show the earliest decrease in functional activity?
Maximum concentration of vitamin A is found in which organ?
Vitamin D absorption is decreased by ?
True statement about vitamin K is?
A young patient started to take a weight loss medication that acts by inhibiting fat absorption from food. After a few weeks, she developed easy bruising and increased menstrual bleeding. Deficiency of which of the following vitamins is responsible for her condition?
Most potent lipid phase antioxidant:
Fat-Soluble Vitamins: A, D, E, K Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following is NOT a manifestation of vitamin E deficiency?
- A. Posterior column abnormalities
- B. Cerebellar ataxia
- C. Hemolytic anemia
- D. Autonomic dysfunction (Correct Answer)
Explanation: ***Autonomic dysfunction*** - **Autonomic dysfunction** is not typically associated with vitamin E deficiency. Instead, it is commonly seen in conditions like **diabetes mellitus**, Parkinson's disease, or certain inherited neuropathies. - Vitamin E primarily acts as an **antioxidant** and is crucial for neurological and red blood cell health. *Hemolytic anemia* - Vitamin E is an **antioxidant** that protects red blood cell membranes from **oxidative damage**. - Its deficiency can lead to increased fragility and **hemolysis** of red blood cells, resulting in hemolytic anemia, particularly in premature infants. *Posterior column abnormalities* - Vitamin E deficiency can cause **neurological dysfunction** due to oxidative damage to neuronal membranes. - This often manifests as degeneration of the **posterior columns** of the spinal cord, leading to impaired proprioception and vibratory sensation. *Cerebellar ataxia* - The **cerebellum** is highly susceptible to oxidative stress, and vitamin E deficiency can lead to damage in this area. - This damage results in **ataxia**, characterized by impaired coordination, balance, and gait disturbances.
Question 2: Warfarin's mechanism of action is
- A. Inhibiting Vitamin K dependent carboxylation (Correct Answer)
- B. Chelating calcium ions
- C. Inhibiting antithrombin III activity
- D. Inhibiting thrombin activity
Explanation: ***Inhibiting Vitamin K dependent carboxylation*** - **Warfarin** acts as an antagonist to **vitamin K**, competitively inhibiting the enzyme **vitamin K epoxide reductase**. - This prevents the **gamma-carboxylation** of vitamin K-dependent clotting factors (II, VII, IX, X, and proteins C and S), rendering them biologically inactive. *Chelating calcium ions* - **Calcium ions** are essential cofactors in the coagulation cascade, but warfarin does not directly affect their concentration or chelate them. - Anticoagulants that chelate calcium, such as **citrate**, are typically used *in vitro* (e.g., in blood collection tubes), not systemically. *Inhibiting antithrombin III activity* - This mechanism describes the action of **heparin** and its derivatives, which enhance the natural anticoagulant activity of **antithrombin III**. - Warfarin's primary action is on vitamin K metabolism, not on antithrombin III potentiation. *Inhibiting thrombin activity* - Direct thrombin inhibitors (**DTIs**), such as dabigatran and argatroban, directly bind to and inhibit the activity of **thrombin (factor IIa)**. - Warfarin's action is upstream in the coagulation cascade, affecting the synthesis of multiple clotting factors, including prothrombin (the precursor to thrombin).
Question 3: Vitamin A intoxication causes injury to
- A. Lysosomal membranes (Correct Answer)
- B. Protein synthesis
- C. Structural support
- D. Energy metabolism
Explanation: ***Lysosomal membranes*** - **Vitamin A toxicity** destabilizes **lysosomal membranes**, causing release of hydrolytic enzymes - Release of **lysosomal enzymes** leads to uncontrolled enzymatic digestion and cellular injury - This is the **primary mechanism** of tissue damage in hypervitaminosis A *Protein synthesis* - While vitamin A affects **gene expression** and **cellular differentiation**, toxicity does not primarily target protein synthesis - Acute toxic effects are mediated through **membrane damage** rather than ribosomal inhibition *Structural support* - Vitamin A is important for **bone development**, but toxicity does not directly damage structural components - Structural damage occurs **secondarily** due to lysosomal enzyme release and membrane instability *Energy metabolism* - Vitamin A toxicity does not directly disrupt **mitochondrial function** or **ATP production** - Mechanism differs from metabolic poisons that inhibit the **electron transport chain** or **glycolysis**
Question 4: All of the following statements are true except:
- A. 25–α hydroxylation takes place in liver
- B. 1–α hydroxylation takes place in kidney
- C. Daily requirement in the absence of sun–light is 450-600 IU/day
- D. 25(OH)D3 is the most active form of vitamin D (Correct Answer)
Explanation: ***25(OH)D3 is the most active form of vitamin D*** - This statement is incorrect. While **25(OH)D3 (calcifediol)** is the major circulating form of vitamin D, it is not the most active form. - The most active form of vitamin D is **1,25(OH)2D3 (calcitriol)**, which is formed by the 1-alpha hydroxylation of calcifediol in the kidneys. *25–α hydroxylation takes place in liver* - This statement is true. The initial hydroxylation of **vitamin D3 (cholecalciferol)** at the 25-position occurs in the liver, forming 25(OH)D3 (calcifediol). - This step is catalyzed by the enzyme **25-hydroxylase**. *1–α hydroxylation takes place in kidney* - This statement is true. The 25(OH)D3 produced in the liver is then transported to the kidneys, where it undergoes a second hydroxylation at the 1-alpha position. - This step, catalyzed by **1-alpha-hydroxylase**, forms the biologically active hormone 1,25(OH)2D3 (calcitriol). *Daily requirement in the absence of sun–light is 450-600 IU/day* - This statement is generally true. The recommended daily allowance (RDA) for vitamin D in adults, especially in the absence of sufficient sun exposure, typically ranges from **400 to 800 IU (international units)**, with 600 IU/day being a common guideline. - This requirement can vary based on age, geographical location, and other individual factors.
Question 5: Which of the following clotting factors in a patient on Warfarin therapy would show the earliest decrease in functional activity?
- A. Factor VII (Correct Answer)
- B. Factor IX
- C. Factor X
- D. Prothrombin (Factor 2)
Explanation: ***Factor VII*** - Factor VII has the **shortest half-life** (approximately 6 hours) among the vitamin K-dependent clotting factors, meaning its functional activity decreases **most rapidly** after starting warfarin therapy. - Warfarin inhibits vitamin K epoxide reductase, preventing gamma-carboxylation of **all vitamin K-dependent factors** (II, VII, IX, X). However, Factor VII's short half-life means pre-existing functional Factor VII is depleted first. - This is why **PT/INR** (which measures the extrinsic pathway dependent on Factor VII) rises before aPTT in warfarin therapy. - Reduced gamma-carboxylation impairs Factor VII's ability to bind calcium and phospholipids, essential for its activation in the extrinsic coagulation pathway. *Factor IX* - Factor IX is a **vitamin K-dependent factor** affected by warfarin, but its longer half-life (approximately 24 hours) means functional activity decreases more slowly than Factor VII. - It plays a key role in the **intrinsic coagulation pathway**. *Factor X* - Factor X is a **vitamin K-dependent clotting factor** whose gamma-carboxylation is inhibited by warfarin. - Its half-life (approximately 40 hours) is longer than Factor VII, resulting in a **slower decline in functional activity**. *Prothrombin (Factor II)* - Prothrombin (Factor II) is a **vitamin K-dependent factor** affected by warfarin. - It has the **longest half-life** (60-72 hours) among vitamin K-dependent factors, meaning its functional levels decrease most slowly after initiating warfarin therapy.
Question 6: Maximum concentration of vitamin A is found in which organ?
- A. Liver (Correct Answer)
- B. Kidney
- C. Lung
- D. Heart
Explanation: ***Liver*** - The **liver** is the primary organ for **storage of vitamin A** (retinyl esters), accounting for 90% of the body's total vitamin A content. - **Hepatic stellate cells** within the liver are specialized for storing the majority of this fat-soluble vitamin. *Kidney* - The **kidney** plays a role in **vitamin D metabolism** and excretion, but not significant vitamin A storage. - While it helps regulate blood levels of various substances, it does not accumulate large quantities of vitamin A. *Lung* - The **lung** does not serve as a major storage site for **vitamin A**. - Its primary functions are related to **gas exchange**, not nutrient storage. *Heart* - The **heart** is responsible for **pumping blood** throughout the body and has minimal involvement in vitamin A storage. - It utilizes certain vitamins for its metabolic processes but does not act as a primary reservoir.
Question 7: Vitamin D absorption is decreased by ?
- A. Proteins
- B. Acid
- C. Lactose
- D. Fat malabsorption (Correct Answer)
Explanation: ***Fat malabsorption*** - **Vitamin D** is a **fat-soluble vitamin**, meaning it requires dietary fat for proper absorption in the small intestine. - Conditions causing **fat malabsorption**, such as **cystic fibrosis**, **celiac disease**, or **pancreatic insufficiency**, significantly reduce the uptake of vitamin D. *Proteins* - **Proteins** do not directly decrease vitamin D absorption; in fact, some dietary proteins can enhance vitamin D binding and transport in the bloodstream. - Their primary role is in structural and enzymatic functions, not impeding fat-soluble vitamin uptake. *Acid* - **Gastric acid** is important for the absorption of some nutrients, but it generally does not directly hinder the absorption of **fat-soluble vitamins** like vitamin D. - Conditions like **achlorhydria** primarily affect the absorption of minerals and vitamin B12, rather than vitamin D. *Lactose* - **Lactose** is a sugar found in milk, and its malabsorption (lactose intolerance) primarily causes gastrointestinal symptoms like bloating and diarrhea. - It does not directly interfere with the absorption of **fat-soluble vitamins**; rather, it affects carbohydrate digestion.
Question 8: True statement about vitamin K is?
- A. Vitamin K is needed for action of clotting factor 8
- B. Vitamin K deficiency leads to DVT
- C. Vitamin K is water soluble
- D. Vitamin K affects bone health by activating proteins that bind calcium (Correct Answer)
Explanation: ***Vitamin K affects bone health by activating proteins that bind calcium*** - Vitamin K plays a crucial role in **osteocalcin activation**, a protein essential for integrating calcium into the bone matrix. - This activation process involves **gamma-carboxylation of glutamic acid residues** on osteocalcin, allowing it to bind calcium and strengthen bone. *Vitamin K is needed for action of clotting factor 8* - Vitamin K is essential for the activation of **clotting factors II, VII, IX, and X**, as well as proteins C and S, through gamma-carboxylation. - **Factor VIII** (antihemophilic factor A) is not directly dependent on vitamin K for its activation. *Vitamin K deficiency leads to DVT* - Vitamin K deficiency primarily leads to **impaired blood clotting** and an increased risk of bleeding, not DVT. - DVT (deep vein thrombosis) is typically associated with **hypercoagulable states**, venous stasis, or endothelial injury. *Vitamin K is water soluble* - Vitamin K is a **fat-soluble vitamin**, meaning it is absorbed with fats in the diet and stored in the body's fatty tissues and liver. - Water-soluble vitamins include **B vitamins and vitamin C**, which are not stored to the same extent and are excreted in urine.
Question 9: A young patient started to take a weight loss medication that acts by inhibiting fat absorption from food. After a few weeks, she developed easy bruising and increased menstrual bleeding. Deficiency of which of the following vitamins is responsible for her condition?
- A. Vitamin E
- B. Vitamin K (Correct Answer)
- C. Vitamin B6
- D. Vitamin D
Explanation: ***Vitamin K*** - The patient is taking a **weight-loss medication** that **inhibits fat absorption**, leading to a deficiency in **fat-soluble vitamins**, including vitamin K. - **Vitamin K** is crucial for the synthesis of **coagulation factors** (II, VII, IX, X), and its deficiency leads to impaired clotting, manifesting as **easy bruising** and **increased menstrual bleeding**. *Vitamin E* - While vitamin E is a fat-soluble vitamin, its deficiency typically causes **neurological dysfunction** and **hemolytic anemia**, not bleeding diathesis. - Although malabsorption of vitamin E can occur with fat malabsorption, it does not directly explain the bleeding symptoms observed. *Vitamin B6* - Vitamin B6 is a **water-soluble vitamin**, so its absorption would not be directly affected by a medication inhibiting fat absorption. - Its deficiency can cause **neuropathy**, **dermatitis**, and **anemia**, but not increased bleeding. *Vitamin D* - Vitamin D is a **fat-soluble vitamin** whose deficiency is associated with **bone disorders** like **osteomalacia** and **rickets**, not bleeding. - While its absorption would be impacted by the medication, its deficiency would not cause easy bruising or increased menstrual bleeding.
Question 10: Most potent lipid phase antioxidant:
- A. Vitamin A
- B. Vitamin E (Correct Answer)
- C. Vitamin C
- D. Vitamin K
Explanation: ***Vitamin E*** - **Vitamin E** (primarily alpha-tocopherol) is a **fat-soluble antioxidant** that is highly effective at neutralizing **lipid peroxyl radicals** within cell membranes and lipoproteins, making it the most potent lipid-phase antioxidant. - It protects against **oxidative damage** to **polyunsaturated fatty acids** in lipid bilayers, which is crucial for maintaining cell membrane integrity. *Vitamin A* - **Vitamin A** (retinol and its derivatives) has antioxidant properties, particularly **beta-carotene**, which can scavenge **single oxygen radicals**. - However, its primary role is not as potent a lipid-phase chain-breaking antioxidant compared to vitamin E. *Vitamin C* - **Vitamin C** (ascorbic acid) is a **water-soluble antioxidant** that works primarily in aqueous environments, such as the cytosol and plasma. - It regenerates expended vitamin E by reducing the **tocopheroxyl radical**, but it doesn't directly act in the lipid phase. *Vitamin K* - **Vitamin K** is essential for **blood coagulation** and **bone metabolism**, serving as a cofactor for gamma-glutamyl carboxylase. - While it has some very limited antioxidant activity in specific contexts, it is not considered a significant or potent antioxidant, especially in the lipid phase.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free